- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HLB Pharmaceutical Co Ltd (047920)
HLB Pharmaceutical Co Ltd stock price live, this page displays KQ 047920 stock exchange data. View the 047920 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the HLB Pharmaceutical Co Ltd real time stock price chart below.
What Is the HLB Pharmaceutical Co Ltd Stock Price Today?
The HLB Pharmaceutical Co Ltd stock price today is 7,660.
What Is the Stock Symbol for HLB Pharmaceutical Co Ltd?
The stock symbol for HLB Pharmaceutical Co Ltd is "047920."
What Stock Exchange Does HLB Pharmaceutical Co Ltd Trade On?
HLB Pharmaceutical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is HLB Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether HLB Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 047920 quote. (ISIN: KR7047920004)
What Is the HLB Pharmaceutical Co Ltd Stock Price Today?
The HLB Pharmaceutical Co Ltd stock price today is 7,660.
What Is the Stock Symbol for HLB Pharmaceutical Co Ltd?
The stock symbol for HLB Pharmaceutical Co Ltd is "047920."
What Stock Exchange Does HLB Pharmaceutical Co Ltd Trade On?
HLB Pharmaceutical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is HLB Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether HLB Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 047920 quote. (ISIN: KR7047920004)
KOSDAQ
Currency in KRW
7,660
+290(+3.93%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7,470
7,950
52 wk Range
6,000
22,250
047920 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7,4707,950
52 wk Range
6,00022,250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
047920 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-2.00 / --
Revenue / Forecast
62.28B / --
Compare 047920 to Peers and Sector
Metrics to compare | 047920 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship047920PeersSector | |
|---|---|---|---|---|
P/E Ratio | 89.9x | −4.7x | −0.4x | |
PEG Ratio | −1.69 | 0.01 | 0.00 | |
Price/Book | 1.9x | 0.9x | 2.6x | |
Price / LTM Sales | 1.0x | 0.7x | 3.1x | |
Upside (Analyst Target) | - | 136.8% | 49.0% | |
Fair Value Upside | Unlock | 22.7% | 7.1% | Unlock |
HLB Pharmaceutical Co., Ltd. researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxant, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dental drugs, multivitamins, parasistic skin disese drugs, dermatlogicals, agents for urogenital organ, amino acid agent, antitussive, mucolytic agents, anthelmintics, antidiarrheals, circulatory system drug, vitamins, skin softeners, anti-hemorrhoid drugs, and agents for liver disease. It is also developing CTT-004 for the treatment of ataxia induced by spinocerebellar degeneration; and offers CMO services. The company was formerly known as Mediforum Pharmaceutical Incorporation and changed its name to HLB Pharmaceutical Co., Ltd in October 2020. HLB Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Namyangju-si, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the HLB Pharmaceutical (047920) Stock Price Today?
The HLB Pharmaceutical stock price today is 7,660 KRW.
What Stock Exchange Does HLB Pharmaceutical Trade On?
HLB Pharmaceutical is listed and trades on the KOSDAQ.
What Is the Stock Symbol for HLB Pharmaceutical?
The stock symbol for HLB Pharmaceutical is "047920."
What Is the HLB Pharmaceutical Market Cap?
As of today, HLB Pharmaceutical market cap is 241.73B KRW.
What Is HLB Pharmaceutical's Earnings Per Share (TTM)?
The HLB Pharmaceutical EPS (TTM) is 83.
From a Technical Analysis Perspective, Is 047920 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has HLB Pharmaceutical Stock Split?
HLB Pharmaceutical has split 1 times.
How Many Employees Does HLB Pharmaceutical Have?
HLB Pharmaceutical has 197 employees.
What is the current trading status of HLB Pharmaceutical (047920)?
As of Sep 03, 2026, HLB Pharmaceutical (047920) is trading at a price of 7,660 KRW, with a previous close of 7,370 KRW. The stock has fluctuated within a day range of 7,470 KRW to 7,950 KRW, while its 52-week range spans from 6,000 KRW to 22,250 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.